ESC Premium Access

A proteomic analysis of 131 biomarkers in relation to infarct size and long-term ejection fraction assessed by CMR in patients with ST-segment elevation myocardial infarction

Topic: Infarction acute phase STEMI

Congress Session

About the speaker

Doctor Moman Aladdin Mohammad

Skane University Hospital, Lund (Sweden)
0 follower

70 more presentations in this session

Acquired thrombocytopenia after transcatheter aortic valve implantation (TAVI): association with clinical outcome

Speaker: Doctor C. Espada Guerreiro (Vila Nova de Gaia, PT)

Thumbnail

Ventricular conduction blocks: prevalence, temporal evolution, and impact on survival in cardiogenic shock

Speaker: Doctor H. Tolppanen (Helsinki, FI)

Thumbnail

Pre-hospital and in-hospital mortality from myocardial infarction in Berlin

Speaker: Assistant Professor M. Stockburger (Nauen, DE)

Thumbnail

Development of antithrombotic therapy and bleeding complications in patients with ACS over time: Data from a local myocardial infarction registry

Speaker: Doctor J. Roehnisch (Berlin, DE)

Thumbnail

8-hydroxy-2-deoxyguanosine predicts microvascular obstruction after primary percutaneous coronary intervention in patients with anterior ST-segment elevation myocardial infarction.

Speaker: Mr Y. Minamimoto (Yokohama, JP)

Thumbnail

Access the full session

Poster session 6 - Latest on STEMI

Speakers: Doctor M. Mohammad, Doctor C. Espada Guerreiro, Doctor H. Tolppanen, Assistant Professor M. Stockburger, Doctor J. Roehnisch...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk